HC Wainwright & Co. Initiates Coverage On Intensity Therapeutics with Buy Rating, Announces Price Target of $5
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has initiated coverage on Intensity Therapeutics with a Buy rating and set a price target of $5.
October 31, 2024 | 11:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has initiated coverage on Intensity Therapeutics with a Buy rating and a price target of $5, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $5 by a reputable analyst firm like HC Wainwright & Co. is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100